Coeptis Therapeutics, Inc. (COEP)
NASDAQ: COEP · IEX Real-Time Price · USD
0.286
-0.012 (-3.99%)
At close: Jul 19, 2024, 4:00 PM
0.294
+0.008 (2.87%)
Pre-market: Jul 22, 2024, 7:01 AM EDT
Coeptis Therapeutics Market Cap
Coeptis Therapeutics has a market cap or net worth of $10.62 million as of July 22, 2024. Its market cap has decreased by -69.58% in one year.
Market Cap
10.62M
Enterprise Value
6.51M
1-Year Change
-69.58%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since October 30, 2020, Coeptis Therapeutics's market cap has decreased from $92.60M to $10.62M, a decrease of -88.54%. That is a compound annual growth rate of -44.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 10.60M | -60.30% |
| Dec 29, 2023 | 26.70M | -11.30% |
| Dec 30, 2022 | 30.10M | -67.91% |
| Dec 31, 2021 | 93.80M | -4.67% |
| Dec 31, 2020 | 98.40M | 6.26% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 11.16M |
| Dominari Holdings | 10.98M |
| Mustang Bio | 10.94M |
| Traws Pharma | 10.92M |
| Inhibikase Therapeutics | 10.82M |
| MIRA Pharmaceuticals | 10.18M |
| Moleculin Biotech | 9.97M |
| ABVC BioPharma | 9.95M |